Mangoceuticals, Inc. (MGRX)
Mangoceuticals, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $0.47, up 0.41% on the session, giving a market capitalisation of $7.9M. On trailing twelve-month figures it carries a trailing P/E of -0.40, a net margin of -4791.5%. Its beta of 2.05 implies it has historically moved more than the broad market.
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Mangoceuticals, Inc. is most often compared with the following Healthcare names: